{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-082520","form_type":"8-K","ticker":"XENE","cik":"0001582313","company_name":"Xenon Pharmaceuticals Inc.","filed_at":"2026-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.530168+00:00","generated_at":"2026-05-15T23:03:18.667076+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Xenon files $400M ATM equity prospectus supplement; $291M already sold under prior program","bullets":["Filed prospectus supplement to register up to $400M of common shares for at-the-market (ATM) sales.","Prior ATM sales total $291,084,564 as of filing date; prior program terminated.","Sales agents are Jefferies and Stifel; shares issuable under Sales Agreement dated Aug 2020 as amended.","Registration statement automatically effective on Form S-3 filed Aug 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-082520","json":"https://secwatch.observer/filing/0001193125-26-082520.json","markdown":"https://secwatch.observer/filing/0001193125-26-082520.md","text":"https://secwatch.observer/filing/0001193125-26-082520.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1582313/000119312526082520/0001193125-26-082520-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1582313/000119312526082520/xene-20260227.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T23:03:18.667076+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}